LBF20115PG05: Difference between revisions

No edit summary
 
(21 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}


Line 4: Line 6:
|LipidBank=XPR1789
|LipidBank=XPR1789
|LipidMaps=-
|LipidMaps=-
|SysName=9a,11a-dihydroxy-15-oxo- (8b) -prost-5Z-en-1-oic acid
|SysName=(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-cis-5-en-1-oic acid
|Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin F2a&&
|Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin F_2 alpha&&(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-5(Z)-en-1-oic acid&&
|Source=
|Chemical Synthesis=
|Metabolism=
|Biological Activity=8-iso-13,14-dihydro-15-keto PGF2 alpha  weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation.[[Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699|{{RelationTable/GetFirstAuthor|Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699}}]]
}}
}}
{{Lipid/Footer}}

Latest revision as of 08:19, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



8-iso-13,14-dihydro-15-keto Prostaglandin F2α
LBF20115PG05.png
Structural Information
(9α,11α)-Dihydroxy-15-oxo- (8β) -prost-cis-5-en-1-oic acid
  • 8-iso-13,14-dihydro-15-keto Prostaglandin F2α
  • (9α,11α)-Dihydroxy-15-oxo- (8β) -prost-5(Z)-en-1-oic acid
Formula C20H34O5
Exact Mass 354.240624198
Average Mass 354.48096000000004
SMILES C(CCC(=O)CC[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC
Physicochemical Information
8-iso-13,14-dihydro-15-keto PGF2 alpha weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation. Cranshaw_JH et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20115PG05 See above. Cranshaw_JH et al. 2001